Factors Associated with Drug Consumption Without Scientific Evidence in Patients with Mild COVID-19 in Peru.
Fecha
2022Autor
Soriano-Moreno, D.R.
Fernandez-Guzman, D.
Sangster-Carrasco, L.
Quispe-Vicuña, C.
Grados-Espinoza, P.
Ccami-Bernal, F.
Morocho-Alburqueque, N.
Coba-Villan, N.
Velasquez-Fernandez, R.
Nieto- Gutierrez, W.
Metadatos
Mostrar el registro completo del ítemResumen
Objective This study aimed to evaluate the factors associated with the consumption of drugs without scientific evidence in patients with mild COVID-19 infection in Peru. Methods An analytical cross-sectional study was carried out including 372 adult patients with a history of mild COVID-19 disease. Factors associated with drug consumption were evaluated by Poisson regressions with robust variance adjustment using the bootstrapping resampling method. Results Seventy-two percent consumed some medication without scientific evidence, with antibiotics (71%) and ivermectin for human use (68%) being the most commonly used. Factors associated with the consumption of drugs to treat mild COVID-19 infection were thinking that the drugs are not effective (adjusted prevalence ratio, 0.55; 95% confidence interval, 0.41-0.74) and not being informed about the efficacy of the drugs (adjusted prevalence ratio, 0.48; 95% confidence interval, 0.36-0.65). Conclusions Education of the population seems to be the main factor that increases the consumption of drugs without scientific evidence in the Peruvian population to treat mild COVID-19.







